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Oversensing of extracardiac myopotentials can lead to
pacemaker inhibition and loss of cardiac output. We describe
2 similar cases in which oversensing of myopotentials and
loss of pacemaker output in pacemaker-dependent patients
was caused by a proprietary algorithm designed to prevent
T-wave sensing. Switching off the algorithm resulted in
return of normal pacemaker function. Knowledge of this
algorithm is essential for patient safety and avoidance of a
potentially unnecessary invasive procedure to reposition
a lead.
Case report
In case 1, an 81-year-old man with ischemic cardiomyopathy
and a dual-chamber pacemaker implanted for complete
atrioventricular block was upgraded to a cardiac resynchro-
nization therapy and deﬁbrillator device. The right ventric-
ular (RV) pacing lead was extracted and replaced with an
implantable cardiac deﬁbrillator (ICD) lead (Durata; St Jude
Medical) positioned at the RV apex and a left ventricular lead
(Quartet; St Jude Medical) in an optimal suitable coronary
venous tributary. The pulse generator (Quadra Assura; St
Jude Medical) was programmed to DDDR mode (60–130
bpm). The following day the patient was observed to have
ventricular pauses lasting over 5 seconds (Figure 1A).
In case 2, a 69-year-old man with ischemic cardiomyop-
athy and dual-chamber pacemaker (Identity ADx XL DR; St
Jude Medical) implanted for complete atrioventricular block
underwent an upgrade to a cardiac resynchronization therapy
and deﬁbrillator device. An ICD lead (Optisure; St Jude
Medical) was placed in the RV apex and a quadripolar left
ventricular lead (Quartet; St JudeMedical, St Paul, MN) in theKEYWORDS Low-frequency attenuation ﬁlter; Oversensing; Myopotentials
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was capped and abandoned. The pre-existing bipolar right
atrial lead (5076; Medtronic) was connected to the new pulse
generator (Quadra Assura MP; St Jude Medical) and the
system programmed to VVI 60 bpm because the patient
remained in atrial ﬁbrillation. The following day, the patient
was noted to have ventricular pauses up to 3.8 seconds
(Figure 1B).
In both cases, clinical and imaging assessment showed no
evidence of lead perforation or dislodgement (Figure 1C).
Device interrogation at rest, with pocket manipulation, and
with isometric exercise revealed stable capture thresholds,
sensing, and impedances (Figures 2A and 3A). However,
deep inspiration and coughing reproduced inhibition of
pacing output, with high-frequency low-amplitude noise
recorded on the near-ﬁeld channel (Figures 2B and 3B).
This effect was independent of pacing polarity, pacing
output, and pacing mode. Decreasing the RV channel
sensitivity from 0.5 mV (nominal) to 1.0 mV abolished
oversensing and pacing inhibition with respiratory maneu-
vers (Figures 2C and 3C). There was concern that the
proprietary low-frequency attenuation (LFA) ﬁlter might be
responsible for loss of pacing output. Inactivation of this
feature without reducing RV channel sensitivity prevented
further oversensing at rest and with respiratory maneuvers
(Figures 2D and 3D).Discussion
In both cases, the LFA ﬁlter, a proprietary signal-processing
algorithm designed to prevent T-wave oversensing (TWOS),
resulted in failure of pacing output in pacemaker-dependent
patients. The LFA ﬁlter was introduced in the St Jude
Medical Unify and Fortify devices and is a combination of
a high-pass ﬁlter and Brady ﬁlter.1 The LFA ﬁlter and the
Brady ﬁlters share a similar center frequency. The LFA ﬁlter
has a faster roll-off slope below 20 Hz, allowing for
additional attenuation of low-frequency content. Compared
with the existing Tachy ﬁlter, the LFA ﬁlter is able to
increase R to T wave amplitude ratio by a factor ofpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 When interrogating an apparently malfunctioning
pacing system it is important to perform respiratory
and physical maneuvers together with imaging
assessment.
 In pacemaker-dependent patients myopotential
oversensing is an uncommon idiosyncratic problem
that can be exacerbated by a proprietary St Jude
Medical low-frequency attenuation (LFA) ﬁlter,
with subsequent inhibition and failure of pacing
output.
 Deactivation of the LFA ﬁlter can eliminate
myopotential oversensing without the need for
invasive interventions or a reduction in lead
sensitivity.
287Hunyor et al Algorithm Causing Pacing Failureapproximately 2–3. The ampliﬁcation of high-frequency
signals enhances sensing performance but in this case
predisposes to diaphragmatic myopotential oversensing.
The LFA ﬁlter is nominally “ON” in the new generation of
St Jude Medical high-voltage devices (including the Fortify/
Unify/Quadra Assura and Ellipse models). The nominal
sensitivity when the LFA ﬁlter is ON is 0.5 mV, whereas
when the LFA ﬁlter is OFF it is 0.3 mV. In both clinical
scenarios, deactivation of the ﬁlter resolved the issue without
the need for invasive interventions or making the RV channel
less sensitive (Figures 2D and 3D).
Our cases illustrate the importance of performing respira-
tory and physical maneuvers when interrogating an apparently
malfunctioning pacing system. An important differentialA
B
C
Figure 1 Representative cardiac telemetry recordings show failure of pacing (a
posteroanterior chest x-ray showing the 3 leads in situ at the locations documentediagnosis is lead perforation, including microperforation by
the lead tip screw mechanism. In the context of a recent
extraction procedure and/or new RV lead implantation,
perforation and lead migration with diaphragmatic myopo-
tential oversensing must be considered. However, high-output
pacing through the RV lead did not capture and stimulate the
diaphragm, making this scenario unlikely. Careful clinical and
imaging assessment is necessary to exclude this serious
complication.
Intracardiac or extracardiac oversensing in the ICD
population has an estimated prevalence of 7.9%.2
Pacemaker-dependent patients are particularly vulnerable
to far-ﬁeld myopotential oversensing, with serious conse-
quences such as syncope owing to inhibition of ventricular
pacing or inappropriate shocks.3 The prevalence of dia-
phragmatic myopotential oversensing in pacemaker-
dependent patients has been estimated at 8.6%–18.9% in
the cardiac resynchronization therapy population.3,4 Well-
described associations include unipolar or integrated bipolar
sensing conﬁgurations, inadvertent DF-1 connector inver-
sion at implantation, apical lead placement, and dynamic
sensitivity adjustment in the presence of low-amplitude R
waves.4,5 In patients with integrated bipolar sensing, inad-
vertent inversion of the DF-1 connector creates a larger
sensing ﬁeld, which incorporates upper limb and pectoral
myopotential sensing. In that case, myopotential “noise” is
noted with upper limb maneuvers, and surgical correction is
mandatory. Oversensing of diaphragm myopotentials may be
corrected by reducing ventricular sensitivity if ventricular
ﬁbrillation (VF) sensing is reliable. Figures 2C and 3C show
the persistence of high-frequency low-amplitude noise, with
deep inspiration, on the near-ﬁeld channel. This noise is not
sensed when setting the channel at a lower sensitivity of 1.0
mV. However, “blanket” programming the RV channel torrows) the day after device implantation in A: case 1 and B: case 2. C: A
d at implant for case 2.
A  B  
C  D  
Figure 3 Intracardiac electrograms from patient in case 2. Electrogram set-up and sweep speed is as described in Figure 2. A: Low-frequency attenuation
(LFA) ﬁlter ON at nominal sensitivity 0.5 mV with normal quiet breathing. B: LFA ﬁlter ON at nominal sensitivity 0.5 mV with deep inspiration maneuvers.
High-frequency, low-amplitude “noise” is seen on the right ventricular near-ﬁeld electrogram channel with associated inhibition of pacing (arrow). C: LFA ﬁlter
ON at a sensitivity 1.0 mV (least sensitive) with deep breathing. Noise is seen on the near ﬁeld (arrow); however, owing to the low sensitivity setting on the right
ventricular near-ﬁeld channel (1.0 mV), no oversensing or pacing inhibition is observed. D: LFA ﬁlter OFF at nominal sensitivity 0.3 mV and deep inspiration.
Diaphragmatic myopotential noise (arrowhead) is not ampliﬁed, owing to absence of LFA ﬁlter algorithm operation; therefore, no oversensing is observed.
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Figure 2 Intracardiac electrograms from patient in case 1. Shown from top to bottom: lead II AutoGain; marker channel; atrial bipolar electrogram; right
ventricular near ﬁeld; and left ventricular distal tip 1 to mid-pole 2. Sweep speed 25 mm/s. A: Low-frequency attenuation (LFA) ﬁlter ON at nominal sensitivity
0.5 mVwith normal quiet breathing.B: LFAON at nominal sensitivity 0.5 mVwith deep inspiration maneuvers. High-frequency, low-amplitude “noise” seen on
near-ﬁeld electrogram channel with associated inhibition of pacing (arrow). C: LFA ﬁlter ON at a sensitivity of 1.0 mV (least sensitive) with deep breathing.
Noise is seen again on the near ﬁeld (arrow); however, owing to the low sensitivity setting on the right ventricular near ﬁeld channel (1.0 mV), no oversensing or
pacing inhibition is observed. D: LFA ﬁlter OFF at nominal sensitivity 0.3 mV and deep inspiration. Diaphragmatic myopotential noise (arrowhead) is not
ampliﬁed, owing to absence of LFA ﬁlter algorithm operation; therefore, no oversensing is observed.
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testing, with its inherent risks, may therefore be prudent.
Finally, when the LFA ﬁlter is inactivated, the RV near-ﬁeld
sensitivity reverts to its nominal value of 0.3 mV, increasing
the risk of TWOS. Very low amplitude noise (diaphragm
myopotentials) is seen with deep inspiration; however, this is
not sensed, as it is not ampliﬁed.
In these cases, we postulate that in the presence of an
operative LFA ﬁlter, ampliﬁcation of diaphragmatic myo-
potentials may result in intermittent oversensing and pace-
maker output inhibition. To our knowledge, this has not been
described and likely represents an uncommon reaction to this
algorithm. The apparent infrequency of this observation is
probably a function of anatomic variation and lead position
in relation to the diaphragm. It is also likely that this
phenomenon is often not recognized, particularly in patients
who are not pacemaker dependent. Knowledge of this
algorithm is essential for patient safety and avoidance of a
likely unnecessary invasive procedure to reposition the lead.
In the appropriate clinical context, recognizing the potential
role of the LFA ﬁlter in apparent failure of pacemaker output
is important. Inactivation of the LFA ﬁlter should partic-
ularly be considered in pacemaker-dependent patients.
Device interrogation with respiratory maneuvers should be
repeated after its inactivation, prior to making the ventricular
channel less sensitive or performing an invasive procedure
for correction. Conversely, inactivation of the LFA ﬁlter
algorithm should prompt greater surveillance for TWOS.
In both cases, changing the sensitivity from 0.5 mV to 1.0
mV abolished diaphragmatic myopotential oversensing, but
concerns regarding VF undersensing led to the decision toinactivate the LFA ﬁlter with reversion to nominal sensitivity
(0.3 mV). This prevented further signiﬁcant oversensing and
therefore pacemaker output inhibition, at rest and on deep
inspiration. At this new nominal sensitivity, with the LFA
ﬁlter “OFF,” deﬁbrillation testing was performed in case 2
and was successful at 25 J. No TWOS was observed in either
case after the programming change.Conclusion
In clinical practice, the LFA ﬁlter appears effective in
minimizing TWOS. The observed myopotential oversensing
appears to be an uncommon complication of the algorithm,
in pacemaker-dependent patients.References
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